financetom
Business
financetom
/
Business
/
Brown & Brown Faces Limited Upside Amid Marco Uncertainties, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brown & Brown Faces Limited Upside Amid Marco Uncertainties, Morgan Stanley Says
Mar 25, 2025 9:09 AM

11:15 AM EDT, 03/25/2025 (MT Newswires) -- Brown & Brown ( BRO ) faces limited near-term upside relative to peers amid macro uncertainties, Morgan Stanley said Tuesday in a note.

The insurance company's "valuation is a bit too hot," and the strong year-to-date stock performance makes the shares "less attractive," Morgan Stanley said.

"Longer term, we continue to believe the fundamentals will outpace peers," and "we are big believers" in the long-term growth and margin outlook, the report said.

Morgan Stanley downgraded its rating on Brown & Brown ( BRO ) stock to equalweight from overweight and retained its price target of $128.

Brown & Brown ( BRO ) shares rose 0.5% in recent Tuesday trading.

Price: 121.52, Change: +0.54, Percent Change: +0.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Walmart Insider Sold Shares Worth $21,020,505, According to a Recent SEC Filing
Walmart Insider Sold Shares Worth $21,020,505, According to a Recent SEC Filing
Mar 14, 2024
06:01 PM EDT, 03/14/2024 (MT Newswires) -- S Robson Walton, 10% Owner, Director, on March 12, 2024, sold 345,000 shares in Walmart ( WMT ) for $21,020,505. Following the Form 4 filing with the SEC, Walton has control over a total of 3,661,746,798 shares of the company, with 7,029,144 shares held directly and 3,654,717,654 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/104169/000112760224010166/xslF345X03/form4.xml Price:...
Aquestive Therapeutics' Anaphylm Demonstrates Faster Maximum Concentration Reach in Phase 3 Trial
Aquestive Therapeutics' Anaphylm Demonstrates Faster Maximum Concentration Reach in Phase 3 Trial
Mar 14, 2024
06:00 PM EDT, 03/14/2024 (MT Newswires) -- Aquestive Therapeutics ( AQST ) said Thursday its sublingual film epinephrine experimental drug Anaphylm showed exposure levels comparable to autoinjectors and was quicker to reach maximum concentration in a phase 3 study. The two-part study focused on pharmacokinetics, the way a drug is absorbed, and pharmacodynamics, the way it affects the body, of...
Wood pellet maker Enviva previews contract shakeup in bankruptcy
Wood pellet maker Enviva previews contract shakeup in bankruptcy
Mar 14, 2024
* Enviva ( EVA ) restructuring aims to cut $1 billion in debt * Company seeks to renegotiate long-term biofuel contracts * German energy co RWE says it is owed $349 million By Dietrich Knauth NEW YORK, March 14 (Reuters) - Bankrupt wood pellet manufacturer Enviva Inc ( EVA ) plans to renegotiate long-term biofuel supply agreements and resolve a...
Antero Resources Insider Sold Shares Worth $736,357, According to a Recent SEC Filing
Antero Resources Insider Sold Shares Worth $736,357, According to a Recent SEC Filing
Mar 14, 2024
06:01 PM EDT, 03/14/2024 (MT Newswires) -- Sheri Pearce, Senior Vice President, Accounting and Chief Accounting Officer, on March 13, 2024, sold 28,009 shares in Antero Resources ( AR ) for $736,357. Following the Form 4 filing with the SEC, Pearce has control over a total of 106,698 shares of the company, with 106,698 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433270/000110465924034602/xslF345X03/tm248897-1_4seq1.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved